Valhalla Charitable Foundation

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 4, 2025	Octave Bioscience	$51.1M Debt / Series C	—	BlueCross BlueShield Venture Partners, Brook Byers, Casdin Capital, Hikma Ventures, Intermountain Ventures, Merck, Northpond Ventures, Novartis, Section 32, Silicon Valley Bank
Mar 4, 2016	Lightsail	$11.0M Series B	Signe Ostby	Bezos Family Foundation

Total Raised

N/A

Valuation

N/A